200 related articles for article (PubMed ID: 32767997)
21. Preventable risk factors of dementia: Population attributable fractions in a Brazilian population-based study.
Borelli WV; Leotti VB; Strelow MZ; Chaves MLF; Castilhos RM
Lancet Reg Health Am; 2022 Jul; 11():100256. PubMed ID: 36778926
[TBL] [Abstract][Full Text] [Related]
22. Tracing the temporal trends of modifiable risk factors in dementia: insights from the English Longitudinal Study of Ageing (2004-2019).
Chen S; Kuper H
Lancet; 2023 Nov; 402 Suppl 1():S34. PubMed ID: 37997075
[TBL] [Abstract][Full Text] [Related]
23. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
[TBL] [Abstract][Full Text] [Related]
24. Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort.
Gottesman RF; Albert MS; Alonso A; Coker LH; Coresh J; Davis SM; Deal JA; McKhann GM; Mosley TH; Sharrett AR; Schneider ALC; Windham BG; Wruck LM; Knopman DS
JAMA Neurol; 2017 Oct; 74(10):1246-1254. PubMed ID: 28783817
[TBL] [Abstract][Full Text] [Related]
25. Population attributable fraction of modifiable risk factors for dementia in Chile.
Vergara RC; Zitko P; Slachevsky A; San Martin C; Delgado C
Alzheimers Dement (Amst); 2022; 14(1):e12273. PubMed ID: 35229017
[TBL] [Abstract][Full Text] [Related]
26. Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers.
Hackenhaar FS; Josefsson M; Adolfsson AN; Landfors M; Kauppi K; Hultdin M; Adolfsson R; Degerman S; Pudas S
Alzheimers Res Ther; 2021 Jul; 13(1):130. PubMed ID: 34266503
[TBL] [Abstract][Full Text] [Related]
27. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors.
Ritchie K; Carrière I; Ritchie CW; Berr C; Artero S; Ancelin ML
BMJ; 2010 Aug; 341():c3885. PubMed ID: 20688841
[TBL] [Abstract][Full Text] [Related]
28. Primary prevention of dementia: focus on modifiable risk factors.
Srisuwan P
J Med Assoc Thai; 2013 Feb; 96(2):251-8. PubMed ID: 23936994
[TBL] [Abstract][Full Text] [Related]
29. Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: A COSMIC collaboration cohort study.
Lipnicki DM; Makkar SR; Crawford JD; Thalamuthu A; Kochan NA; Lima-Costa MF; Castro-Costa E; Ferri CP; Brayne C; Stephan B; Llibre-Rodriguez JJ; Llibre-Guerra JJ; Valhuerdi-Cepero AJ; Lipton RB; Katz MJ; Derby CA; Ritchie K; Ancelin ML; Carrière I; Scarmeas N; Yannakoulia M; Hadjigeorgiou GM; Lam L; Chan WC; Fung A; Guaita A; Vaccaro R; Davin A; Kim KW; Han JW; Suh SW; Riedel-Heller SG; Roehr S; Pabst A; van Boxtel M; Köhler S; Deckers K; Ganguli M; Jacobsen EP; Hughes TF; Anstey KJ; Cherbuin N; Haan MN; Aiello AE; Dang K; Kumagai S; Chen T; Narazaki K; Ng TP; Gao Q; Nyunt MSZ; Scazufca M; Brodaty H; Numbers K; Trollor JN; Meguro K; Yamaguchi S; Ishii H; Lobo A; Lopez-Anton R; Santabárbara J; Leung Y; Lo JW; Popovic G; Sachdev PS;
PLoS Med; 2019 Jul; 16(7):e1002853. PubMed ID: 31335910
[TBL] [Abstract][Full Text] [Related]
30. Age-related disparities in diabetes risk attributable to modifiable risk factor profiles in Chinese adults: a nationwide, population-based, cohort study.
Wang T; Zhao Z; Wang G; Li Q; Xu Y; Li M; Hu R; Chen G; Su Q; Mu Y; Tang X; Yan L; Qin G; Wan Q; Gao Z; Yu X; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Zeng T; Chen L; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Zhao J; Shi L; Xu Y; Xu M; Chen Y; Wang S; Lu J; Bi Y; Ning G; Wang W
Lancet Healthy Longev; 2021 Oct; 2(10):e618-e628. PubMed ID: 36098018
[TBL] [Abstract][Full Text] [Related]
31. Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors.
Gallagher D; Kiss A; Lanctot KL; Herrmann N
J Clin Psychiatry; 2018 Nov; 80(1):. PubMed ID: 30549490
[TBL] [Abstract][Full Text] [Related]
32. Modifiable dementia risk score to study heterogeneity in treatment effect of a dementia prevention trial: a post hoc analysis in the preDIVA trial using the LIBRA index.
van Middelaar T; Hoevenaar-Blom MP; van Gool WA; Moll van Charante EP; van Dalen JW; Deckers K; Köhler S; Richard E
Alzheimers Res Ther; 2018 Jun; 10(1):62. PubMed ID: 29960597
[TBL] [Abstract][Full Text] [Related]
33. Examination of potentially modifiable dementia risk factors across the adult life course: The Framingham Heart Study.
Hwang PH; Ang TFA; De Anda-Duran I; Liu X; Liu Y; Gurnani A; Mez J; Auerbach S; Joshi P; Yuan J; Devine S; Au R; Liu C
Alzheimers Dement; 2023 Jul; 19(7):2975-2983. PubMed ID: 36656649
[TBL] [Abstract][Full Text] [Related]
34. Potential for prevention of dementia in Denmark.
Jørgensen K; Nielsen TR; Nielsen A; Waldemar G
Alzheimers Dement; 2023 Oct; 19(10):4590-4598. PubMed ID: 36933232
[TBL] [Abstract][Full Text] [Related]
35. Potentially modifiable dementia risk factors in all Australians and within population groups: an analysis using cross-sectional survey data.
See RS; Thompson F; Russell S; Quigley R; Esterman A; Harriss LR; Hyde Z; Taylor S; Radford K; LoGiudice D; McDermott R; Livingston G; Strivens E
Lancet Public Health; 2023 Sep; 8(9):e717-e725. PubMed ID: 37633680
[TBL] [Abstract][Full Text] [Related]
36. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
[TBL] [Abstract][Full Text] [Related]
37. Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index.
Vos SJB; van Boxtel MPJ; Schiepers OJG; Deckers K; de Vugt M; Carrière I; Dartigues JF; Peres K; Artero S; Ritchie K; Galluzzo L; Scafato E; Frisoni GB; Huisman M; Comijs HC; Sacuiu SF; Skoog I; Irving K; O'Donnell CA; Verhey FRJ; Visser PJ; Köhler S
J Alzheimers Dis; 2017; 58(2):537-547. PubMed ID: 28453475
[TBL] [Abstract][Full Text] [Related]
38. Association of Modifiable Health Conditions and Social Determinants of Health With Late Mortality in Survivors of Childhood Cancer.
Ehrhardt MJ; Liu Q; Dixon SB; Caron E; Redd D; Shelton K; Huang IC; Bhakta N; Ness KK; Mulrooney DA; Brinkman TM; Chemaitilly W; Delaney A; Armstrong GT; Srivastava DK; Zaidi A; Robison LL; Yasui Y; Hudson MM
JAMA Netw Open; 2023 Feb; 6(2):e2255395. PubMed ID: 36763361
[TBL] [Abstract][Full Text] [Related]
39. APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.
Qian J; Wolters FJ; Beiser A; Haan M; Ikram MA; Karlawish J; Langbaum JB; Neuhaus JM; Reiman EM; Roberts JS; Seshadri S; Tariot PN; Woods BM; Betensky RA; Blacker D
PLoS Med; 2017 Mar; 14(3):e1002254. PubMed ID: 28323826
[TBL] [Abstract][Full Text] [Related]
40. Independent and joint effects of vascular and cardiometabolic risk factor pairs for risk of all-cause dementia: a prospective population-based study.
Shaaban CE; Jia Y; Chang CH; Ganguli M
Int Psychogeriatr; 2019 Oct; 31(10):1421-1432. PubMed ID: 31455442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
